The dominant B2B news brand for biotech. Delivering news, revealing insights straight to your inbox.
Joined December 2008
- Tweets 29,558
- Following 627
- Followers 102,330
- Likes 415
168 Photos and videos
Eli Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate,’ while putting Incyte on notice #EHA26 fiercebiotech.com/biotech/li…
1
8
4,945
Jun 12
Chutes & Ladders—Perrigo CEO ousted over ‘personal conduct’ fiercebiotech.com/biotech/ch…
1
4
2,313
Jun 12
Novartis' phase 1/2 win tees up regulatory talks about dystrophy drug from $12B Avidity takeover fiercebiotech.com/biotech/no…
1
9
2,043
Jun 12
‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing fiercebiotech.com/biotech/af…
8
1,371
Jun 12
Today on The Top Line, Fierce EIC @AylaEllison sits down with Ipsen's R&D chief to discuss the biopharma's approach to partnerships, its strategy for expanding the pipeline, and where its focus is in 2026. fiercebiotech.com/biotech/ip…
1
7
1,804
Jun 11
AI use is surging across HHS, jumping 148% at the FDA in 2025 fiercehealthcare.com/ai-and-…
1
5
2,045
Jun 11
Three Genentech VPs are among those dismissed in another round of layoffs by the Roche subsidiary. fiercebiotech.com/biotech/ge…
1
2
2,987
Jun 11
Caribou Biosciences has linked its CAR-T cell therapy candidate to 17.1-month median progression-free survival, adding to evidence that the off-the-shelf treatment can match the efficacy of autologous products in lymphoma patients. fiercebiotech.com/biotech/ca…
2
13
1,985
Jun 11
Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year. fiercebiotech.com/biotech/ta…
1
1
8
1,943
Jun 11
Cardiovascular-focused Kardigan plans to bring in cozy $320M haul from upcoming IPO fiercebiotech.com/biotech/ca…
5
1,705
Jun 11
‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO fiercepharma.com/pharma/if-t…
2
14
2,965
Jun 10
GLP-1s may combat depression by multiplying a mood-boosting gut microbe fiercebiotech.com/research/g…
2
3
4
2,296
Jun 10
From executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry fiercebiotech.com/cro/execut…
2
1,581
Jun 10
Sanofi halts phase 3 autoimmune trial early over insufficient efficacy as pipeline woes continue fiercebiotech.com/biotech/sa…
1
1
9
4,190
Jun 10
Even as industry watchers pit the two obesity assets against one another, it’s too early to say whose next-generation incretin stands supreme between Novo Nordisk’s CagriSema and Eli Lilly’s retatrutide, Novo’s chief scientific officer has suggested to Fierce fiercebiotech.com/biotech/ad…
1
9
2,479
Jun 10
Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for the largest listing in the biotech sector’s history. fiercebiotech.com/biotech/ca…
2
10
1,952
Jun 9
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer in lung cancer. fiercebiotech.com/biotech/gs…
1
3
1,826
Jun 9
Bial has stopped development in a subpopulation of Parkinson’s disease patients after its phase 2b trial missed its primary endpoint. fiercebiotech.com/biotech/bi…
1
1
1,723
Jun 8
Clinical-stage cancer biotech Treeline sees path to public markets via reverse merger fiercebiotech.com/biotech/se…
1
8
2,639
Jun 8
City aims to lay foundation for RNAi renaissance with nearly $100M series B fiercebiotech.com/biotech/ci…
6
2,188